Transparency: Patented Medicine Prices Review Board
Patented Medicine Prices Review Board (PMPRB) information, data, publications and reports.
Like all federal departments and agencies, the PMPRB regularly reports to Parliament on its activities and spending.
Under the Patent Act, the PMPRB is required to submit an Annual Report to Parliament that outlines its activities and the results of its analyses of various price trends in the pharmaceutical industry.
Services and Information
Departmental Plan
Annual reports on the department’s priorities, programs, expected results and expenditure plans.
Departmental Results Report
The departmental results report used to measure performance against what is outlined in the reports on plans and priorities.
Sustainable Development
Departmental Sustainable Development Strategy (DSDS) and progress reports outlining departmental contributions to the Government of Canada’s sustainable development goals.
Fees reports
Annual fees reports which describe the listing of all fees, service standards and performance results, and financial information.
Quarterly Financial Reports: Patented Medicine Prices Review Board
Quarterly financial reports, including year-to-date highlights, information on risks, and changes to operations, personnel and programs.
Audits and evaluations
Annual reports of audit and evaluations for programs and services.
Proactive disclosure
Proactive disclosure reports on financial and human resources-related information.
Access to Information and Privacy: Patented Medicine Prices Review Board
Information about the Access to Information Act and Privacy Act.
Annual reports on travel, hospitality and conference expenses
Information on the annual expenditures for each of travel, hospitality and conference fees.
Annual Report on the Fighting Against Forced Labour and Child Labour in Supply Chains Act
Annual report that details the steps taken to prevent and reduce the risk that forced labour or child labour.
Page details
- Date modified: